MCF Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $701K | Buy |
6,320
+29
| +0.5% | +$3.22K | 0.05% | 116 |
|
|
2025
Q1 | $705K | Sell |
6,291
-488
| -7% | -$54.7K | 0.05% | 112 |
|
|
2024
Q4 | $626K | Buy |
6,779
+2,111
| +45% | +$195K | 0.04% | 118 |
|
|
2024
Q3 | $391K | Sell |
4,668
-86
| -2% | -$7.21K | 0.03% | 161 |
|
|
2024
Q2 | $326K | Sell |
4,754
-2,594
| -35% | -$178K | 0.02% | 173 |
|
|
2024
Q1 | $538K | Buy |
7,348
+152
| +2% | +$11.1K | 0.04% | 131 |
|
|
2023
Q4 | $583K | Buy |
7,196
+573
| +9% | +$46.4K | 0.05% | 119 |
|
|
2023
Q3 | $496K | Buy |
6,623
+424
| +7% | +$31.8K | 0.04% | 120 |
|
|
2023
Q2 | $478K | Sell |
6,199
-248
| -4% | -$19.1K | 0.04% | 126 |
|
|
2023
Q1 | $535K | Buy |
6,447
+200
| +3% | +$16.6K | 0.05% | 116 |
|
|
2022
Q4 | $536K | Buy |
6,247
+1,664
| +36% | +$143K | 0.05% | 109 |
|
|
2022
Q3 | $283K | Buy |
4,583
+882
| +24% | +$54.5K | 0.03% | 166 |
|
|
2022
Q2 | $229K | Sell |
3,701
-452
| -11% | -$28K | 0.02% | 174 |
|
|
2022
Q1 | $247K | Buy |
+4,153
| New | +$247K | 0.02% | 173 |
|
|
2021
Q4 | – | Sell |
-2,991
| Closed | -$209K | – | 288 |
|
|
2021
Q3 | $209K | Buy |
2,991
+1,145
| +62% | +$80K | 0.02% | 178 |
|
|
2021
Q2 | $127K | Buy |
1,846
+1,539
| +501% | +$106K | 0.01% | 212 |
|
|
2021
Q1 | $20K | Buy |
+307
| New | +$20K | ﹤0.01% | 365 |
|
|
2016
Q4 | – | Sell |
-34
| Closed | -$3K | – | 450 |
|
|
2016
Q3 | $3K | Hold |
34
| – | – | ﹤0.01% | 399 |
|
|
2016
Q2 | $3K | Buy |
+34
| New | +$3K | ﹤0.01% | 433 |
|
|
2015
Q2 | – | Sell |
-115
| Closed | -$11K | – | 440 |
|
|
2015
Q1 | $11K | Hold |
115
| – | – | ﹤0.01% | 316 |
|
|
2014
Q4 | $11K | Hold |
115
| – | – | ﹤0.01% | 299 |
|
|
2014
Q3 | $12K | Buy |
+115
| New | +$12K | ﹤0.01% | 302 |
|